Mate, read the pdf, it matches 100% what Wayne said, to be fair at the beginning he said he had 25 years experience in pharmaceuticals which was not in the pdf other than that all the same.
cheers
- Forums
- ASX - By Stock
- AVR
- Tissue Engineering v. Immunotherapy
Tissue Engineering v. Immunotherapy, page-4
-
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$12.19 |
Change
-0.010(0.08%) |
Mkt cap ! $257.6M |
Open | High | Low | Value | Volume |
$12.19 | $12.20 | $11.60 | $173.1K | 14.51K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9 | $11.97 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.19 | 28 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 9 | 11.970 |
1 | 1000 | 11.680 |
2 | 520 | 11.600 |
1 | 1000 | 11.500 |
1 | 80 | 11.250 |
Price($) | Vol. | No. |
---|---|---|
12.190 | 28 | 1 |
12.200 | 1789 | 1 |
12.500 | 500 | 1 |
12.850 | 99 | 1 |
13.300 | 200 | 1 |
Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
BM8
BATTERY AGE MINERALS LTD
Nigel Broomham, CEO
Nigel Broomham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online